Your nose may know more when it comes to COVID-19
UC expert says loss of smell could be an early indicator of infection
A University of Cincinnati ear, nose and throat specialist says your nose may hold a clue in identifying COVID-19. The loss of smell may be a key indicator.
Physicians are increasingly recognizing the importance of the nasal cavity in determining the physiology of COVID-19, explains Ahmad Sedaghat, an associate professor in the UC College of Medicine’s Department of Otolaryngology-Head and Neck Surgery and an UC Health physician specializing in diseases of the nose and sinuses.
“COVID-19 is not associated with the symptoms that are typically associated with a viral cold such as nasal blockage or mucus production,” says Sedaghat. “This distinction is also why it is fairly easy to distinguish COVID-19 from seasonal allergies."
“COVID-19 is associated with a fairly unique combination of nasal symptoms: a sudden loss of one’s sense of smell, also known as ‘anosmia,’ without nasal obstruction,” said Sedaghat. “The occurrence of sudden onset anosmia without nasal obstruction is highly predictive of COVID-19 and should trigger the individual to immediately self-quarantine with presumptive COVID-19.”
Most individuals experiencing COVID-19 report symptoms two to 14 days after exposure such as fever, cough and shortness of breath. Medical assistance is needed if individuals have trouble breathing, persistent pressure or pain in the chest or confusion or inability to rouse, according to the Centers for Disease Control and Prevention. For most, recovery comes without assistance.
Sedaghat’s conclusions are available online in the scholarly journal Laryngoscope Investigative Otolaryngology, where he explains that anosmia without nasal obstruction is “a highly specific indicator of COVID-19.”
His findings are based on his review of 19 studies which describe the sinus and nasal disorders reported in relation to the current coronavirus plaguing the nation. Sedaghat’s published paper also references a recent study led by Paris physicians Dominique Salmon and Alain Corré, which shows that out of a group of 55 patients presenting with anosmia without nasal obstruction 94% were found to test positive for COVID-19 by nasal swabbing and polymerase chain reaction tests.
Sedaghat said COVID-19 can be spread when the virus, if present in the body, is produced in the lining of the nose and then released into mucus. “When someone sneezes, this mucus — which contains the virus — is aerosolized outwards. Similarly, if someone wipes their nose and then touches surfaces without washing their hands first, that could lead to spread of COVID-19,” explains Sedaghat.
Loss of smell can occur during anytime an individual is infected with COVID-19, but when this occurs as an initial symptom it is particularly instructive, says Sedaghat.
“A sudden loss of one’s sense of smell wouldn’t trigger most people to think they have COVID-19,” explains Sedaghat. “These individuals could continue business as usual and spread the disease as a carrier. The guidelines for when to formally test for COVID-19 remain fluid in the setting of limited tests. But if someone experiences anosmia without nasal obstruction, aside from quarantining, it would not be unreasonable to reach out to one’s primary care physician about getting tested.”
Sedaghat says the nasal cavity is likely the major site of entry and infection by COVID-19 since at least 90% of inhaled air enters the body through the nose. “Nasal virus production is at very high levels and tends to occur early in the disease process while patients are still asymptomatic or having very mild symptoms,” he says.
Other co-authors in the study include Dr. Isabelle Gengler and Dr. James Wang, both residents in the UC Department of Otolaryngology-Head and Neck Surgery, along with Dr. Marlene Speth from Kantonsspital Aarau in Aarau, Switzerland. None of the study authors have conflicts of interest or financial investments to disclose.
Featured image at top of coronavirus/Unsplash.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
UC study examines role of metabolites in disease treatment
June 8, 2023
Each year, about 200,000 people in the United States are diagnosed with a bulge in the lower part of the aorta, the main artery in the body, called an abdominal aortic aneurysm (AAA). New research from the University of Cincinnati examines the role a particular metabolite plays in the development of AAA and could lead to the first treatment of the condition.
UC startups recognized by Cincy Inno for commitment to innovation
June 7, 2023
The University of Cincinnati's entrepreneurial spirit is once again front and center. In a recent Business Courier article touting the finalists in an awards competition by Cincy Inno, 20% were UC-affiliated startups.
Local 12: Study: Targeted drug therapy slows progression of...
June 7, 2023
Research from UC shows potential promise for a drug as a therapy for certain brain tumors. Local 12 interviewed Rekha Chaudry, MD, of the UC College of Medicine about the study results.